Author
Listed:
- Wei-Lun Tsai
- Kwok-Hung Lai
- Huei-Lung Liang
- Ping-I Hsu
- Hoi-Hung Chan
- Wen-Chi Chen
- Hsien-Chung Yu
- Feng-Woei Tsay
- Huay-Min Wang
- Hung-Chih Tsai
- Jin-Shiung Cheng
Abstract
Background and Aim: The optimal treatment for huge unresectable hepatocellular carcinoma (HCC) remains controversial. The outcome of transcatheter arterial chemoembolization (TACE) for patients huge unresectable HCC is generally poor and the survival benefit of TACE in these patients is unclear. The aim of the study is to compare the effect of hepatic arterial infusion chemotherapy (HAIC) versus symptomatic treatment in patients with huge unresectable HCC. Methods: Since 2000 to 2005, patients with huge (size >8cm) unresectable HCC were enrolled. Fifty-eight patients received HAIC and 44 patients received symptomatic treatment. In the HAIC group, each patient received 2.4+1.4 (range: 1–6) courses of HAIC. Baseline characteristics and survival were compared between the HAIC and symptomatic treatment groups. Results: The HAIC group and the symptomatic treatment group were similar in baseline characteristics and tumor stages. The overall survival rates at one and two years were 29% and 14% in the HAIC group and 7% and 5% in the symptomatic treatment group, respectively. The patients in the HAIC group had significantly better overall survival than the symptomatic treatment group (P
Suggested Citation
Wei-Lun Tsai & Kwok-Hung Lai & Huei-Lung Liang & Ping-I Hsu & Hoi-Hung Chan & Wen-Chi Chen & Hsien-Chung Yu & Feng-Woei Tsay & Huay-Min Wang & Hung-Chih Tsai & Jin-Shiung Cheng, 2014.
"Hepatic Arterial Infusion Chemotherapy for Patients with Huge Unresectable Hepatocellular Carcinoma,"
PLOS ONE, Public Library of Science, vol. 9(5), pages 1-5, May.
Handle:
RePEc:plo:pone00:0092784
DOI: 10.1371/journal.pone.0092784
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0092784. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.